HUMINSULIN 30/70 U100

Huminsulin 30/70 Injection Suspension at a concentration of 100 IU/ml is a formulation that combines two types of insulin: one that has an intermediate duration of action and another that acts quickly. This medication is indicated for managing diabetes mellitus, encompassing both type 1 and type 2 diabetes, in individuals of all ages, including children. Its primary function is to aid in regulating blood glucose levels in individuals diagnosed with diabetes, ensuring that these levels are maintained within a safe and healthy range. Typically, Huminsulin 30/70 is prescribed alongside other antidiabetic medications. Patients will receive guidance from healthcare professionals on the correct method of subcutaneous injection. To optimize its effectiveness, it is advised to consume a carbohydrate-containing meal within a half-hour after administration. Patients should not discontinue use without consulting their healthcare provider. This medication is part of a comprehensive treatment strategy that should also encompass a balanced diet, consistent physical activity, and weight management as per medical advice. Regular monitoring of blood glucose levels is crucial; patients should record their results and discuss them with their healthcare provider to determine the most appropriate dosage. One of the primary concerns while using this medication is the risk of hypoglycemia or low blood sugar, which can be mitigated by adhering to prescribed doses, maintaining meal schedules, and frequent blood glucose checks. Excessive alcohol consumption may also lead to reduced blood sugar levels. Additional side effects may include localized reactions at the injection site, such as redness or swelling, potential weight gain, and dermatological reactions like rashes, edema, or itching.